Results 1 to 10 of about 82,991 (273)

Effects of ACE inhibitor and afterload reduction in single ventricles following bidirectional Glenn [PDF]

Open Heart
Background Patients with single ventricles after bidirectional Glenn (BDG) are placed on ACE inhibitors (ACEIs) to reduce afterload and to decrease systemic to pulmonary collateral flow (SPC).
Matthew A Harris, Mark A Fogel, Kevin K Whitehead, David M Biko, Cassie Giner, Andrea L Jones, Karen I Ramirez Suarez, Mariangeles Medina Perez, Danish Vaiyani, Sara Lynn Partington   +9 more
doaj   +2 more sources

Incidence of angiotensin-converting enzyme inhibitor-induced cough in a Malaysian public primary care clinic: A retrospective cohort study [PDF]

Malaysian Family Physician, 2022
Introduction: The incidence of angiotensin-converting enzyme inhibitors (ACEi)-induced cough has been reported between 5% and 30% but is unknown in Malaysia.
Hou Chan Loo, Fairuz Osman, Siew Lee Ho, Sing Yee An, Yim Mei Au Yong, Ee Ming Khoo   +5 more
doaj   +1 more source

A Real-World Analysis of Post-Marketing Surveillance Data Assessing the Incidence of Hyperkalemia or Acute Kidney Injury in Patients on Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin-Receptor Blockers

Reviews in Cardiovascular Medicine, 2023
Background: The widely used Renin-angiotensin-aldosterone system inhibitor (RASI) may increase the risk of hyperkalemia and acute kidney injury (AKI). We aimed to analyze the RASI-related AKI or hyperkalemia reported in the Food and Drug Administration’s
Yining Wang, Qidong Ren, HuiTing Luo, Gang Chen, Bin Zhao, Xuemei Li   +5 more
doaj   +1 more source

Acute Decompensated Heart Failure in Patients With and Without COVID-19 — The Experience of a Romanian Center

Romanian Journal of Cardiology, 2022
Our goal was to characterize a cohort of heart failure patients with and without COVID-19 in terms of demographics, comorbid conditions, treatment regimens, lab test results and outcome.
Vintilă Ana-Maria, Horumbă Mihaela, Miron Paul, Balan Răzvan, Catrangiu Maria-Beatrice, Negoescu Iris-Andreea, Trifan Iuliana, Vintilă Vlad-Damian, Gurghean Adriana, Săvulescu-Fiedler Ilinca   +9 more
doaj   +1 more source

Effect of angiotensin converting enzyme inhibitors on the development of chronic subdural haematoma

Biomedical Papers, 2021
Aims. Angiotensin converting enzyme inhibitors (ACEI) have been recently discussed in connection with the medical treatment of chronic subdural haematoma (CSDH). They may improve the treatment results.
Premysl Stejskal, Miroslav Vaverka, Stefan Trnka, Martin Hampl, Lumir Hrabalek   +4 more
doaj   +1 more source

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes [PDF]

Reviews in Cardiovascular Medicine, 2021
There are limited data regarding the use of angiotensin converting enzyme inhibitors/angiotensin receptor blockers (ACEi/ARBs) in acute heart failure (AHF).
Kevin Bryan Lo, Hesam Mostafavi Toroghi, Grace Salacup, Jiahui Jiang, Ruchika Bhargav, Eduardo Quintero, Kira Balestrini, Anum Shahzad, Roy O. Mathew, Peter A McCullough, Janani Rangaswami   +10 more
doaj   +1 more source

Angiotensin-Converting Enzyme Inhibitor Induced Cough in Chinese Patients: a Systematic Review and Meta-analysis

Journal of Pharmacy & Pharmaceutical Sciences, 2021
Purpose: To determine the risk of angiotensin converting enzyme inhibitor (ACEI)-induced cough compared to non-ACEI cough among Chinese patients. Methods: A comprehensive search was conducted including randomized controlled trials, case-control studies ...
Ling Liang, Janice, Y Kung, Bradley Mitchelmore, Jasmine Gill, Andrew Cave, Hoan Linh Banh   +5 more
doaj   +1 more source

The effect of RAAS inhibitors on acute hypoxemic respiratory failure and in-hospital mortality in the hypertensive Covid-19 patients

Clinical and Experimental Hypertension, 2021
Introduction We have aimed to investigate the relationship between use of angiotensin-converting-enzyme inhibitor (ACEI) or angiotensin-receptor-blocker (ARB) drugs and acute hypoxemic respiratory failure (AHRF) and in-hospital mortality in hypertensive ...
Abdurrahman Akyüz, Ferhat Işık, Burhan Aslan, Murat Çap, İlyas Kaya, Özgür Atlı, Ümit İnci, Ercan Taştan, Adem Aktan, Önder Bilge, Metin Okşul, Emre Aydın, Zülküf Karahan, Derya Deniz Altıntaş, Rojhat Altındağ, Mehmet Şahin Adıyaman, Bernas Altıntaş   +16 more
doaj   +1 more source

Supplementary data for “Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study” [PDF]

, 2020
Additional information regarding study design, baseline cohort characteristics, and results of sensitivity ...
Bidulka, Patrick, Iwagami, Masao, Tomlinson, Laurie A., Wong, Angel Y.S.   +3 more
core   +1 more source

Angiotensin-Converting Enzyme (ACE) Inhibitors and Pancreatitis: A Potential Dose-dependent Relationship

European Journal of Case Reports in Internal Medicine, 2020
Acute pancreatitis (AP) remains one of the most common causes of emergency department visits in the USA. The literature supports an association between angiotensin-converting enzyme inhibitors (ACEi), mainly at steady-state doses, and AP.
Murtaza Hussain, Smit S Deliwala, Anoosha Ponnapalli, Viraj Modi, Ashok Kanagula, Mamoon M Elbedawi, Ghassan Bachuwa   +6 more
doaj   +1 more source